(Stroke. 2001;32:2712.)
© 2001 American Heart Association, Inc.
Special Report |
From the School of Medicine, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, Va.
Correspondence to Hermes A. Kontos, MD, PhD, School of Medicine, Virginia Commonwealth University, Medical College of Virginia Campus, Richmond, VA 23298. E-mail hakontos{at}vcu.edu
Abstract The sequential univalent reduction of oxygen generates superoxide, hydrogen peroxide, and hydroxyl radical. The generation of hydroxyl radical is dependent on catalysis by ferrous iron. In addition, superoxide and nitric oxide produce peroxynitrite, which spontaneously generates hydroxyl radical independently of iron-mediated catalysis. These agents have a variety of cellular actions, which render them suitable candidates as mediators of tissue destruction and cellular death. In the intact brain, superoxide and its derivatives cause vasodilation, mediated by opening of potassium channels, altered vascular reactivity, breakdown of the blood-brain barrier, and focal destructive endothelial lesions. These abnormalities are also seen in early reperfusion following brain ischemia. During reperfusion there is a marked transient increase in superoxide production. Vasodilation, abnormal vascular reactivity, and blood-brain barrier breakdown are inhibited by eliminating superoxide. Superoxide production during reperfusion may be initiated by glutamate via activation of
-amino-3-hydroxy-5-methylisoxasolepropionic acid (AMPA) receptors. These experimental findings have important implications for human cerebral ischemia. Agents directed at eliminating oxygen radicals must be administered before or in the early stages of reperfusion following ischemia. The therapeutic window appears to be narrow and limited to, at most, a few hours. The inhibition of AMPA receptors may be a promising approach to inhibit the production of oxygen radicals during ischemia-reperfusion of the brain.
Key Words: glutamates hydrogen peroxide hydroxyl radical nitrates superoxides receptors, AMPA receptors, NMDA vasodilation
This article has been cited by other articles:
![]() |
B. R.S. Broughton, D. C. Reutens, and C. G. Sobey Apoptotic Mechanisms After Cerebral Ischemia Stroke, May 1, 2009; 40(5): e331 - e339. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Kelly, J. D. Morrow, M. Ning, W. Koroshetz, E. H. Lo, E. Terry, G. L. Milne, J. Hubbard, H. Lee, E. Stevenson, et al. Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke: The Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) Study Stroke, January 1, 2008; 39(1): 100 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hong, J.-S. Zeng, D. L. Kreulen, D. I. Kaufman, and A. F. Chen Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2210 - H2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Fagan, D. C. Hess, E. J. Hohnadel, D. M. Pollock, and A. Ergul Targets for Vascular Protection After Acute Ischemic Stroke Stroke, September 1, 2004; 35(9): 2220 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gursoy-Ozdemir, A. Can, and T. Dalkara Reperfusion-Induced Oxidative/Nitrative Injury to Neurovascular Unit After Focal Cerebral Ischemia Stroke, June 1, 2004; 35(6): 1449 - 1453. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Danton and W. D. Dietrich The Search for Neuroprotective Strategies in Stroke AJNR Am. J. Neuroradiol., February 1, 2004; 25(2): 181 - 194. [Full Text] [PDF] |
||||
![]() |
E. Tanaka, S. Niiyama, S. Sato, A. Yamada, and H. Higashi Arachidonic Acid Metabolites Contribute to the Irreversible Depolarization Induced by In Vitro Ischemia J Neurophysiol, November 1, 2003; 90(5): 3213 - 3223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Didion, M. J. Ryan, L. A. Didion, P. E. Fegan, C. D. Sigmund, and F. M. Faraci Increased Superoxide and Vascular Dysfunction in CuZnSOD-Deficient Mice Circ. Res., November 15, 2002; 91(10): 938 - 944. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Cipolla and A. B. Curry Middle Cerebral Artery Function After Stroke: The Threshold Duration of Reperfusion for Myogenic Activity Stroke, August 1, 2002; 33(8): 2094 - 2099. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |